Lannin Natasha A, Crotty Maria, Cameron Ian D, Chen Zhibin, Ratcliffe Julie, Morarty Jacqui, Turner-Stokes Lynne
Department of Neuroscience, Monash University, Melbourne, Victoria, Australia
Alfred Health, Melbourne, Victoria, Australia.
BMJ Open. 2024 Dec 22;14(12):e094892. doi: 10.1136/bmjopen-2024-094892.
To adapt and apply a model for evaluating the functional benefits and cost efficiency of specialist inpatient rehabilitation to the Australian context, comparing functional outcomes and savings in the cost of ongoing care after acquired brain injury.
An observational cohort analysis of prospectively collected clinical data from admission to discharge, with follow-up to 3 years.
A newly established state-wide inpatient postacute rehabilitation unit in Victoria, Australia for patients with moderate to severe acquired brain injury.
This study included consecutive patients admitted to the programme during its first 2 years' operation (January 2016 to December 2017). Inclusion criteria consisted of complete outcome measures recorded on admission and discharge, total n=196, mean age 44.6 years (range 17-78), males:females 72:28%, aetiology:trauma n=124 (63%), stroke n=42 (21%), diffuse n=18 (9%) and other-mixed n=12 (7%).
Specialist inpatient multidisciplinary rehabilitation.
Dependency and care costs: Northwick Park Dependency Scale/Care Needs Assessment (NPCNA); Functional independence: UK Functional Assessment Measure. Cost efficiency: (a) Time is taken to offset rehabilitation costs by savings in NPCNA-estimated costs of ongoing care and (b) net projected lifetime savings.
Median length of stay 75 (IQR: 33.5-169.5) days, mean episode costs were $A147 044 (95% CI $A126 436, $A167 652). There was a significant reduction in dependency between admission and discharge on all measures (Holm-Bonferroni corrected p<0.001) which was sustained at follow-up in those traced at 1-3 years. Savings were greatest in the highest-dependency group. Estimated mean overall reduction in 'weekly care costs' was $A7206, offsetting the cost of rehabilitation within 5.53 months (95% CI 2.27, 8.78). Mean projected net lifetime savings were $A13.4 million (95% CI $A11.4, $A15.4) per patient.
This study provides proof of principle for use of the NPCNA cost-efficiency model outside the UK and yields further evidence that rehabilitation for patients with complex disabilities represents value for money. For every dollar spent on inpatient rehabilitation in this cohort, an estimated $A91 was saved in ongoing care costs.
调整并应用一个评估专科住院康复功能效益和成本效益的模型至澳大利亚的情况,比较获得性脑损伤后功能结局和持续护理成本的节省情况。
对前瞻性收集的从入院到出院的临床数据进行观察性队列分析,并随访3年。
澳大利亚维多利亚州一个新设立的全州性急性后期住院康复单元,收治中重度获得性脑损伤患者。
本研究纳入该项目运营前两年(2016年1月至2017年12月)连续入院的患者。纳入标准包括入院和出院时记录的完整结局测量指标,共n = 196例,平均年龄44.6岁(范围17 - 78岁),男性:女性为72:28%,病因:创伤n = 124例(63%),中风n = 42例(21%),弥漫性病变n = 18例(9%),其他 - 混合性病变n = 12例(7%)。
专科住院多学科康复。
依赖性和护理成本:诺斯威克公园依赖性量表/护理需求评估(NPCNA);功能独立性:英国功能评估量表。成本效益:(a)通过NPCNA估计的持续护理成本节省来抵消康复成本所需的时间,以及(b)预计的终身净节省。
中位住院时间75天(四分位间距:33.5 - 169.5天),平均每次发作成本为147,044澳元(95%可信区间126,436澳元,167,652澳元)。所有测量指标在入院和出院之间的依赖性均显著降低(经霍尔姆 - 邦费罗尼校正p<0.001),在1 - 3年随访的患者中这种降低持续存在。依赖性最高的组节省最多。估计“每周护理成本”的总体平均降低为7206澳元,在5.53个月内抵消了康复成本(95%可信区间2.27,8.78)。每位患者预计的终身净节省平均为1340万澳元(95%可信区间1140万澳元,1540万澳元)。
本研究为在英国境外使用NPCNA成本效益模型提供了原理证明,并进一步证明了对复杂残疾患者进行康复具有成本效益。在该队列中,每花费1澳元用于住院康复,估计在持续护理成本中可节省91澳元。